The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A

Early diagnosis is essential for improving the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aims to explore the clinical value of lipoprotein subfractions in the diagnosis of hepatitis B virus (HBV)-related HCC. Lipoprotein subfractions were detected by <sup&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Duo Zuo, Haohua An, Jianhua Li, Jiawei Xiao, Li Ren
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	lipidomics <sup>1</sup>H-NMR LC-MS/MS lipoprotein subfractions lipoprotein lipase cancer biomarkers Medicine R
Acceso en línea:	https://doaj.org/article/592a9455abbf438b829c575880ad0588
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:592a9455abbf438b829c575880ad0588
record_format	dspace
spelling	oai:doaj.org-article:592a9455abbf438b829c575880ad05882021-11-25T18:07:31ZThe Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A10.3390/jpm111111432075-4426https://doaj.org/article/592a9455abbf438b829c575880ad05882021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1143https://doaj.org/toc/2075-4426Early diagnosis is essential for improving the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aims to explore the clinical value of lipoprotein subfractions in the diagnosis of hepatitis B virus (HBV)-related HCC. Lipoprotein subfractions were detected by <sup>1</sup>H-NMR spectroscopy, and the pattern-recognition method and binary logistic regression were performed to classify distinct serum profiles and construct prediction models for HCC diagnosis. Differentially expressed proteins associated with lipid metabolism were detected by LC-MS/MS, and the potential prognostic significance of the mRNA expression was evaluated by Kaplan–Meier <i>survival analysis</i>. The diagnostic panel constructed from the serum particle number of very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL-1~LDL-6) achieved higher accuracy for the diagnosis of HBV-related HCC and HBV-related benign liver disease (LD) than that constructed from serum alpha-fetoprotein (AFP) alone in the training set (AUC: 0.850 vs. AUC: 0.831) and validation set (AUC: 0.926 vs. AUC: 0.833). Furthermore, the panel achieved good diagnostic performance in distinguishing AFP-negative HCC from AFP-negative LD (AUC: 0.773). We also found that lipoprotein lipase (LPL) transcript levels showed a significant increase in cancerous tissue and that high expression was significantly positively correlated with the poor prognosis of patients. Our research provides new insight for the development of diagnostic biomarkers for HCC, and abnormal lipid metabolism and LPL-mediated abnormal serum lipoprotein metabolism may be important factors in promoting HCC development.Duo ZuoHaohua AnJianhua LiJiawei XiaoLi RenMDPI AGarticlelipidomics<sup>1</sup>H-NMRLC-MS/MSlipoprotein subfractionslipoprotein lipasecancer biomarkersMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1143, p 1143 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	lipidomics <sup>1</sup>H-NMR LC-MS/MS lipoprotein subfractions lipoprotein lipase cancer biomarkers Medicine R
spellingShingle	lipidomics <sup>1</sup>H-NMR LC-MS/MS lipoprotein subfractions lipoprotein lipase cancer biomarkers Medicine R Duo Zuo Haohua An Jianhua Li Jiawei Xiao Li Ren The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
description	Early diagnosis is essential for improving the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aims to explore the clinical value of lipoprotein subfractions in the diagnosis of hepatitis B virus (HBV)-related HCC. Lipoprotein subfractions were detected by <sup>1</sup>H-NMR spectroscopy, and the pattern-recognition method and binary logistic regression were performed to classify distinct serum profiles and construct prediction models for HCC diagnosis. Differentially expressed proteins associated with lipid metabolism were detected by LC-MS/MS, and the potential prognostic significance of the mRNA expression was evaluated by Kaplan–Meier <i>survival analysis</i>. The diagnostic panel constructed from the serum particle number of very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL-1~LDL-6) achieved higher accuracy for the diagnosis of HBV-related HCC and HBV-related benign liver disease (LD) than that constructed from serum alpha-fetoprotein (AFP) alone in the training set (AUC: 0.850 vs. AUC: 0.831) and validation set (AUC: 0.926 vs. AUC: 0.833). Furthermore, the panel achieved good diagnostic performance in distinguishing AFP-negative HCC from AFP-negative LD (AUC: 0.773). We also found that lipoprotein lipase (LPL) transcript levels showed a significant increase in cancerous tissue and that high expression was significantly positively correlated with the poor prognosis of patients. Our research provides new insight for the development of diagnostic biomarkers for HCC, and abnormal lipid metabolism and LPL-mediated abnormal serum lipoprotein metabolism may be important factors in promoting HCC development.
format	article
author	Duo Zuo Haohua An Jianhua Li Jiawei Xiao Li Ren
author_facet	Duo Zuo Haohua An Jianhua Li Jiawei Xiao Li Ren
author_sort	Duo Zuo
title	The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
title_short	The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
title_full	The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
title_fullStr	The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
title_full_unstemmed	The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
title_sort	application value of lipoprotein particle numbers in the diagnosis of hbv-related hepatocellular carcinoma with bclc stage 0-a
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/592a9455abbf438b829c575880ad0588
work_keys_str_mv	AT duozuo theapplicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT haohuaan theapplicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT jianhuali theapplicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT jiaweixiao theapplicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT liren theapplicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT duozuo applicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT haohuaan applicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT jianhuali applicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT jiaweixiao applicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a AT liren applicationvalueoflipoproteinparticlenumbersinthediagnosisofhbvrelatedhepatocellularcarcinomawithbclcstage0a
_version_	1718411616675954688

The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A

Ejemplares similares